Tag: Oncology

A new review in Molecular Biology Reports summarizes how exosome-based diagnostics are advancing across oncology, neurology, cardiology and infectious disease, ...

A cross-sectional study of 239 hospitalized oncology patients found that functional care needs explained about 10.9 percent of the variance ...

Researchers identified a three-receptor signature involving HRH1, ADRA2B, and CHRM3 that defines glioblastoma aggressiveness and correlates with poor patient survival.

A 78-year-old woman developed hyperactive delirium with hallucinations and persecutory delusions during pembrolizumab therapy, and her symptoms fully resolved after ...

A 129-patient Japanese multicenter study found that tumor PD-L1 expression did not predict the effectiveness of ALK inhibitor therapy in ...

A retrospective cohort of 144 men in Côte d'Ivoire found that 20.8 percent of patients with metastatic castration-resistant prostate cancer ...

A phase 3 trial shows sacituzumab tirumotecan significantly lowers the risk of cancer progression and death in women with recurrent ...

A Phase 1 trial presented at ESMO 2026 reports a 40% objective response rate at 130 mg for ISM6331, a ...

Newsweek’s 2027 hospital ranking placed Gustave Roussy third worldwide based on professional surveys, accreditations, and patient-reported outcome measures.

An edited multidisciplinary volume reviews heterocyclic scaffolds, evaluation methods, emerging drug-design approaches and translational challenges in anticancer research.

A retrospective cohort of 269 breast cancer patients found that GLP-1 receptor agonists produced significant but markedly attenuated weight loss ...

A retrospective study of 2,409 patients found that baseline beta-1 selective beta-blocker therapy was independently associated with higher all-cause mortality, ...

A 346-publication analysis finds rapidly expanding research on SGLT2 inhibitors across cancer safety, antitumor mechanisms, real-world outcomes and cardio-oncology, but ...

An ancillary analysis of the Japanese phase III trial JCOG1013 found that a tumor proportion score of at least 1% ...

A real-world cohort study of 327 patients with EGFR-mutated non-small cell lung cancer finds that continuing EGFR-TKI therapy plus anti-angiogenic ...

Nearly half of patients with multiple myeloma experience pathological fractures, according to a retrospective analysis of 692 cases treated at ...

A study of 1,200 adults with solid tumors presented at ASN Kidney Week 2026 found that creatinine-based and creatinine-plus-cystatin-C estimates ...

A qualitative study of 15 patients finds that fractures during immune checkpoint inhibitor therapy are viewed as "a small price ...

A bibliometric analysis of 540 English-language AI and bone-metastasis publications through June 2026 found rapid growth after 2020, persistent imaging ...

A 2026 perspective proposes a one-way digital shadow for continuous conformity monitoring in certified cancer centers, but notes that the ...